Pfizer says late-stage coronavirus vaccine study shows moderate side effects
Pfizer Inc said on Tuesday participants were showing mild-to-moderate side effects when given either the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study…
Cde
